BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15809491)

  • 21. Biological correlates of FDG uptake in non-small cell lung cancer.
    de Geus-Oei LF; van Krieken JH; Aliredjo RP; Krabbe PF; Frielink C; Verhagen AF; Boerman OC; Oyen WJ
    Lung Cancer; 2007 Jan; 55(1):79-87. PubMed ID: 17046099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
    Bos R; van Der Hoeven JJ; van Der Wall E; van Der Groep P; van Diest PJ; Comans EF; Joshi U; Semenza GL; Hoekstra OS; Lammertsma AA; Molthoff CF
    J Clin Oncol; 2002 Jan; 20(2):379-87. PubMed ID: 11786564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer.
    Chung JK; Lee YJ; Kim SK; Jeong JM; Lee DS; Lee MC
    Nucl Med Commun; 2004 Jan; 25(1):11-7. PubMed ID: 15061260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique.
    Southworth R; Dearling JL; Medina RA; Flynn AA; Pedley RB; Garlick PB
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1334-41. PubMed ID: 12271416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma.
    Charnley N; Airley R; Du Plessis D; West C; Brock C; Barnett C; Matthews J; Symonds K; Bottomly M; Swindell R; Price P
    Oncol Rep; 2008 Sep; 20(3):537-42. PubMed ID: 18695903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats.
    Burcelin R; Printz RL; Kande J; Assan R; Granner DK; Girard J
    Am J Physiol; 1993 Sep; 265(3 Pt 1):E392-401. PubMed ID: 8214048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
    Shim HK; Lee WW; Park SY; Kim H; So Y; Kim SE
    Nucl Med Biol; 2009 Feb; 36(2):191-7. PubMed ID: 19217531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
    Lee JD; Yang WI; Park YN; Kim KS; Choi JS; Yun M; Ko D; Kim TS; Cho AE; Kim HM; Han KH; Im SS; Ahn YH; Choi CW; Park JH
    J Nucl Med; 2005 Oct; 46(10):1753-9. PubMed ID: 16204727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
    Kang F; Ma W; Ma X; Shao Y; Yang W; Chen X; Li L; Wang J
    J Nucl Med; 2014 Mar; 55(3):439-45. PubMed ID: 24504055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading.
    Zhao S; Kuge Y; Tsukamoto E; Mochizuki T; Kato T; Hikosaka K; Nakada K; Hosokawa M; Kohanawa M; Tamaki N
    Nucl Med Commun; 2002 Jun; 23(6):545-50. PubMed ID: 12029209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
    Ahn KJ; Hwang HS; Park JH; Bang SH; Kang WJ; Yun M; Lee JD
    J Nucl Med; 2009 Sep; 50(9):1525-32. PubMed ID: 19690031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of Glut-1 glucose transporter expression with.
    Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.
    Tian M; Zhang H; Nakasone Y; Mogi K; Endo K
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):5-12. PubMed ID: 14551748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary.
    Kurokawa T; Yoshida Y; Kawahara K; Tsuchida T; Okazawa H; Fujibayashi Y; Yonekura Y; Kotsuji F
    Int J Cancer; 2004 May; 109(6):926-32. PubMed ID: 15027127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.
    Christlieb SB; Strandholdt CN; Olsen BB; Mylam KJ; Larsen TS; Nielsen AL; Rohde M; Gerke O; Olsen KE; Møller MB; Kristensen BW; Abildgaard N; Alavi A; Høilund-Carlsen PF
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1824-36. PubMed ID: 27102266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
    Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
    Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging.
    Tian M; Zhang H; Higuchi T; Oriuchi N; Nakasone Y; Takata K; Nakajima N; Mogi K; Endo K
    Ann Nucl Med; 2005 Jun; 19(4):335-8. PubMed ID: 16097646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography.
    Lee JD; Yun M; Lee JM; Choi Y; Choi YH; Kim JS; Kim SJ; Kim KS; Yang WI; Park YN; Han KH; Lee WJ; Yoo N; Lim SM; Park JH
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1621-30. PubMed ID: 15278306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
    Yamada T; Uchida M; Kwang-Lee K; Kitamura N; Yoshimura T; Sasabe E; Yamamoto T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):464-71. PubMed ID: 22676927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Uptake of FDG (2-fluoro-2-deoxy-D-glucose) as a tumor imaging agent into erythrocytes and accumulation of FDG in tumor cells].
    Minosako Y; Nemoto M; Ino S; Shirakami Y; Kurami M
    Kaku Igaku; 2003 Feb; 40(1):23-30. PubMed ID: 12701204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.